Recent Finacing
Recent Raise
Bone Biologics develops Nell-1 (UCB-1), a recombinant skeletal-specific growth-factor platform for bone regenerative medicine, targeting spinal fusion and orthopedic, reconstructive, and sports-medicine applications under clinical/regulatory development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
